Richard S Kollender

CIK 1415666 · President and CFO · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.24M

Companies

6

Total Filings

32

Lifetime Open-Market Net

$50.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPID Director 1,611,327 $1.76 $2.84M $50.1K 9 2026-05-26
Strongbridge Biopharma plc (SBBP) Delisted President and CFO 0 $2.00 $0 $0 10 2021-10-06
Celator Pharmaceuticals Inc (CPXX) Delisted Director 1,327,888 $0 2 2016-07-13
PATH Director 0 $10.55 $0 $0 4 2014-02-24
INSM Director 24,598 $97.85 $2.41M $0 4 2013-11-01
INSMED Inc (INSMD) Delisted Director 17,072,989 $0 1 2011-03-03

Recent Filings · Page 3 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-06-15 Celator Pharmaceuticals Inc (CPXX) Delisted Grant (A) $0 EDGAR
2014-02-24 PATH Mixed −5,334,693 -$19.47M EDGAR
2013-11-01 INSM Exer (M) +8,955 $0 EDGAR
2013-07-31 Other (J) +109,429 $0
2013-06-07 PATH Grant (A) $0 EDGAR
2013-06-05 Grant (A) $0
2013-04-26 PATH Grant (A) +13,500 $0 EDGAR
2013-01-15 INSM Mixed +10,174 $0 EDGAR
2012-01-24 INSM Exer (M) +5,469 $0 EDGAR
2012-01-13 INSM Grant (A) $0 EDGAR
Showing 2130 of 32
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.